BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38591291)

  • 1. Clinicopathological features and outcome of secondary steroid resistant nephrotic syndrome: A retrospective analysis.
    Qaiser H; Bajeer I; Khatri S; Hashmi S; Lanewala AA
    J Pak Med Assoc; 2024 Mar; 74(3):524-527. PubMed ID: 38591291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.
    Wannous H
    Pediatr Nephrol; 2024 Aug; 39(8):2413-2422. PubMed ID: 38587559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for minimal change disease in adults with nephrotic syndrome.
    Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological Spectrum and Short-Term Outcome of Treatment with Cyclophosphamide in Relapsing Steroid-Sensitive Nephrotic Syndrome.
    Bajeer IA; Khatri S; Tresa V; Hashmi S; Mubarak M; Lanewala AA
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):436-439. PubMed ID: 29848418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
    BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease.
    Haddad M; Kale A; Butani L
    BMC Nephrol; 2021 Nov; 22(1):395. PubMed ID: 34839817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-biochemical Profile of Biopsy-proven Minimal Change Disease in Adults from a Tertiary Care Center in South India.
    Udupa KRN; Eshwarappa M; Gurudev KC; Gireesh MS; Reddy R; Yousuff M
    Saudi J Kidney Dis Transpl; 2023 May; 34(3):242-249. PubMed ID: 38231719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome.
    Mason AE; Sen ES; Bierzynska A; Colby E; Afzal M; Dorval G; Koziell AB; Williams M; Boyer O; Welsh GI; Saleem MA;
    Clin J Am Soc Nephrol; 2020 Jul; 15(7):983-994. PubMed ID: 32317330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S; Hirano D; Nishino T; Umeda C; Watanabe Y; Nakagawa M
    Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
    Jung J; Lee JH; Park YS
    Nephron; 2022; 146(4):327-334. PubMed ID: 34929692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.
    Taşdemir M; Canpolat N; Yıldız N; Özçelik G; Benzer M; Saygılı SK; Özkayin EN; Türkkan ÖN; Balat A; Candan C; Çelakıl M; Yavuz S; Akıncı N; Göknar N; Akgün C; Tülpar S; Alpay H; Sever FL; Bilge İ
    Turk J Med Sci; 2021 Aug; 51(4):1781-1790. PubMed ID: 33581711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium.
    Straatmann C; Ayoob R; Gbadegesin R; Gibson K; Rheault MN; Srivastava T; Tran CL; Gipson DS; Greenbaum LA; Smoyer WE; Vehaskari VM
    Pediatr Nephrol; 2013 Aug; 28(8):1235-41. PubMed ID: 23633037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.
    Trautmann A; Schnaidt S; Lipska-Ziętkiewicz BS; Bodria M; Ozaltin F; Emma F; Anarat A; Melk A; Azocar M; Oh J; Saeed B; Gheisari A; Caliskan S; Gellermann J; Higuita LMS; Jankauskiene A; Drozdz D; Mir S; Balat A; Szczepanska M; Paripovic D; Zurowska A; Bogdanovic R; Yilmaz A; Ranchin B; Baskin E; Erdogan O; Remuzzi G; Firszt-Adamczyk A; Kuzma-Mroczkowska E; Litwin M; Murer L; Tkaczyk M; Jardim H; Wasilewska A; Printza N; Fidan K; Simkova E; Borzecka H; Staude H; Hees K; Schaefer F;
    J Am Soc Nephrol; 2017 Oct; 28(10):3055-3065. PubMed ID: 28566477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.